Page last updated: 2024-08-24

topotecan and ly335979

topotecan has been researched along with ly335979 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gnoth, MJ; Grieshop, B; Ickenroth, K; Muenster, U1
Hashimoto, T; Konno, Y; Matsuda, Y; Nagai, M; Satsukawa, M; Taguchi, T; Yamashita, S1

Other Studies

2 other study(ies) available for topotecan and ly335979

ArticleYear
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.
    Pharmaceutical research, 2008, Volume: 25, Issue:10

    Topics: Albendazole; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Line; Cyclosporins; Dibenzocycloheptenes; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Ivermectin; LLC-PK1 Cells; Mice; Quinolines; Ritonavir; Swine; Time Factors; Topotecan; Transfection

2008
In vivo assessment of the impact of efflux transporter on oral drug absorption using portal vein-cannulated rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:8

    Topics: Absorption; Adenosine; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Catheterization; Dibenzocycloheptenes; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Male; Portal Vein; Quinolines; Rats; Rats, Sprague-Dawley; Sulfasalazine; Terfenadine; Topotecan

2013